136 related articles for article (PubMed ID: 2411995)
21. Impact of P-glycoprotein on blood-retinal barrier permeability: comparison of blood-aqueous humor and blood-brain barrier using mdr1a knockout rats.
Fujii S; Setoguchi C; Kawazu K; Hosoya K
Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4650-8. PubMed ID: 24985475
[TBL] [Abstract][Full Text] [Related]
22. Brain to blood efflux transport of adenosine: blood-brain barrier studies in the rat.
Isakovic AJ; Abbott NJ; Redzic ZB
J Neurochem; 2004 Jul; 90(2):272-86. PubMed ID: 15228584
[TBL] [Abstract][Full Text] [Related]
23. Quantitative autoradiographic measurements of blood-brain barrier permeability in the rat glioma model.
Yamada K; Ushio Y; Hayakawa T; Kato A; Yamada N; Mogami H
J Neurosurg; 1982 Sep; 57(3):394-8. PubMed ID: 7097336
[TBL] [Abstract][Full Text] [Related]
24. Comparison of drug permeabilities across the blood-retinal barrier, blood-aqueous humor barrier, and blood-brain barrier.
Toda R; Kawazu K; Oyabu M; Miyazaki T; Kiuchi Y
J Pharm Sci; 2011 Sep; 100(9):3904-11. PubMed ID: 21638281
[TBL] [Abstract][Full Text] [Related]
25. Relationship between in vitro transendothelial permeability and in vivo single-pass brain extraction.
Pirro JP; Di Rocco RJ; Narra RK; Nunn AD
J Nucl Med; 1994 Sep; 35(9):1514-9. PubMed ID: 8071703
[TBL] [Abstract][Full Text] [Related]
26. Kinetic analysis of L-leucine transport across the blood-brain barrier.
Smith QR; Takasato Y; Rapoport SI
Brain Res; 1984 Oct; 311(1):167-70. PubMed ID: 6488039
[TBL] [Abstract][Full Text] [Related]
27. Measurement of cerebral vascular extraction fractions in the rat using intracarotid injection techniques.
Clark HB; Hartman BK; Raichle ME; Preskorn SH; Larson KB
Brain Res; 1981 Mar; 208(2):311-23. PubMed ID: 6783263
[TBL] [Abstract][Full Text] [Related]
28. Effect of intracarotid infusion of etoposide: modification of the permeability of the blood-brain barrier and the blood-tumor barrier in rat brain tumor model.
Maeda Y; Matsumoto K; Mizumatsu S; Tamiya T; Furuta T; Ohmoto T
Acta Med Okayama; 1999 Feb; 53(1):5-11. PubMed ID: 10096732
[TBL] [Abstract][Full Text] [Related]
29. From the Cover: In Vitro and In Vivo Blood-Brain Barrier Penetration Studies with the Novel Cyanide Antidote Candidate Dimethyl Trisulfide in Mice.
Kiss L; Bocsik A; Walter FR; Ross J; Brown D; Mendenhall BA; Crews SR; Lowry J; Coronado V; Thompson DE; Sipos P; Szabó-Révész P; Deli MA; Petrikovics I
Toxicol Sci; 2017 Dec; 160(2):398-407. PubMed ID: 28973547
[TBL] [Abstract][Full Text] [Related]
30. Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability.
Zhang Y; Li CS; Ye Y; Johnson K; Poe J; Johnson S; Bobrowski W; Garrido R; Madhu C
Drug Metab Dispos; 2006 Nov; 34(11):1935-43. PubMed ID: 16896068
[TBL] [Abstract][Full Text] [Related]
31. Impact of capillary flow hydrodynamics on carrier-mediated transport of opioid derivatives at the blood-brain barrier, based on pH-dependent Michaelis-Menten and Crone-Renkin analyses.
Yusof SR; Abbott NJ; Avdeef A
Eur J Pharm Sci; 2017 Aug; 106():274-286. PubMed ID: 28614733
[TBL] [Abstract][Full Text] [Related]
32. Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein.
Lee YJ; Kusuhara H; Jonker JW; Schinkel AH; Sugiyama Y
J Pharmacol Exp Ther; 2005 Jan; 312(1):44-52. PubMed ID: 15448171
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of blood-brain barrier permeability to DL-propranolol by serum from acute renal failure rats.
Lin TH; Sawada Y; Sugiyama Y; Iga T; Hanano M
Biochem Pharmacol; 1987 Oct; 36(20):3425-31. PubMed ID: 3675605
[TBL] [Abstract][Full Text] [Related]
34. Effects of hepatic ischemia-reperfusion injury on the blood-brain barrier permeability to [
Miah MK; Bickel U; Mehvar R
Metab Brain Dis; 2017 Dec; 32(6):1903-1912. PubMed ID: 28779418
[TBL] [Abstract][Full Text] [Related]
35. Dose-dependent brain penetration of SDZ PSC 833, a novel multidrug resistance-reversing cyclosporin, in rats.
Lemaire M; Bruelisauer A; Guntz P; Sato H
Cancer Chemother Pharmacol; 1996; 38(5):481-6. PubMed ID: 8765444
[TBL] [Abstract][Full Text] [Related]
36. Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study.
Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2015 Apr; 204():60-9. PubMed ID: 25724272
[TBL] [Abstract][Full Text] [Related]
37. Effect of human renal and hepatic disease on the pharmacokinetics of anticancer drugs.
Powis G
Cancer Treat Rev; 1982 Jun; 9(2):85-124. PubMed ID: 6181872
[No Abstract] [Full Text] [Related]
38. Influence of blood-brain barrier permeability on O-(2-
Stegmayr C; Bandelow U; Oliveira D; Lohmann P; Willuweit A; Filss C; Galldiks N; Lübke JH; Shah NJ; Ermert J; Langen KJ
Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):408-416. PubMed ID: 27613541
[TBL] [Abstract][Full Text] [Related]
39. Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration.
Heymans M; Sevin E; Gosselet F; Lundquist S; Culot M
Eur J Pharm Biopharm; 2018 Jun; 127():453-461. PubMed ID: 29602020
[TBL] [Abstract][Full Text] [Related]
40. Blood-brain barrier transport of valproic acid.
Cornford EM; Diep CP; Pardridge WM
J Neurochem; 1985 May; 44(5):1541-50. PubMed ID: 3921665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
